Cornercap Investment Counsel’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RA
Cornercap Investment Counsel's HAE Position: Q4 2024 in Review
Cornercap Investment Counsel sold out of Haemonetics (HAE) in Q4 2024, closing a stake of 2,679 shares — an estimated $215K sold.
Cornercap Investment Counsel first reported a position in HAE in Q3 2015 and held it in 14 quarters. The position peaked at $1.32M in Q1 2024. 309 funds tracked by Wall St. Rank hold HAE as of Q4 2024.
- Cornercap Investment Counsel reported no remaining Haemonetics position as of Q4 2024 after selling out during the quarter.
- Cornercap Investment Counsel sold 2,679 Haemonetics shares in Q4 2024, an estimated $215K.
- Cornercap Investment Counsel first reported a position in Haemonetics in Q3 2015 and held it in 14 quarters.
- Cornercap Investment Counsel's Haemonetics position peaked at $1.32M in Q1 2024.
- 309 funds tracked by Wall St. Rank held Haemonetics as of Q4 2024.
Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.